A Crystal Ball For Drug Launch Success? Try Consensus Estimates
Consensus estimates can be a predictor of how a biopharma will perform during a drug launch, a Leerink Swann report shows, citing examples from the last ten years as proof.
Consensus estimates can be a predictor of how a biopharma will perform during a drug launch, a Leerink Swann report shows, citing examples from the last ten years as proof.